SCHEMBL16380596

SCHEMBL16380596

Cc1ccc(Nc2cc(Cl)nc(N)n2)cc1Cl

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLA1 P09884 1/20 0.75
MAPT P10636 4/20 0.62
POLB P06746 2/20 0.61
GAA P10253 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
AGPAT2 O15120 10/20 0.55
CYP3A4 P08684 2/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
KMT2A Q03164 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C19 P33261 1/20 0.54
NPSR1 Q6W5P4 1/20 0.48
RAPGEF4 Q8WZA2 1/20 0.47
ROCK2 O75116 1/20 0.47
MEN1 O00255 1/20 0.47
PKM P14618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13064960 0.88 POLA1 (0.57) POLA1MAPTPOLBGAASMN1; SMN2
SCHEMBL12346224 0.85 POLA1 (0.62) POLA1MAPTPOLBGAASMN1; SMN2
SCHEMBL7741592 0.85 POLA1 (0.62) POLA1MAPTPOLBGAASMN1; SMN2
SCHEMBL7746369 0.83 POLA1 (0.59) POLA1MAPTPOLBGAASMN1; SMN2
SCHEMBL3233125 0.83 MAPT (0.70) POLA1MAPTPOLBGAASMN1; SMN2
SCHEMBL13288394 0.82 POLA1 (0.75) POLA1MAPTPOLBGAASMN1; SMN2
SCHEMBL14050066 0.79 POLA1 (0.61) POLA1MAPTPOLBGAASMN1; SMN2
SCHEMBL29608945 0.79 POLA1 (0.61) POLA1MAPTPOLBGAASMN1; SMN2
SCHEMBL13963086 0.77 CYP1A2 (0.72) POLA1MAPTPOLBGAASMN1; SMN2
SCHEMBL28229117 0.76 POLA1 (0.67) POLA1MAPTPOLBGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921376-B2 Pyrrolopyridines useful as inhibitors of protein kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-12-30 US disclosed